 |
인쇄하기
취소
|
HIRAS to revise economic effectiveness guideline for medicines
The Health Insurance Review Assessment and Service said on April 19 that it is considering modifying the economic effectiveness guideline for medicines by reflecting the recent scientific outcomes and local research situations of pharmaceutical firms.
In a recent working-level gathering with pharmaceutical firms, HIRAS officials said it will evaluate the economic effectiveness of medicines b...
In a recent working-level gathering with pharmaceutical firms, HIRAS officials said it will evaluate the economic effectiveness of medicines b...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.